“A brilliant team who collaborate to deliver innovative discovery cancer science and patient benefit.” This is the refreshed sense of purpose that the Cancer Sciences Unit is bringing to life right now. This is the “Why”. The order of words
I am writing this at the end of national Volunteers’ Week, which is a chance to celebrate and say thank you for the fantastic contribution millions of volunteers make across the UK. The week is marked by local and regional
Last week I was in Norway attending the annual meeting of the RHINESSA study. It is always a pleasure to visit the lovely city of Bergen and catch up with colleagues who have now become friends. This week I am
Last week, Faculty of Medicine staff received an email highlighting local changes to the policy on scientific publishing that are driven by the move to fully compliant open access. Amongst other things, this email mentioned Plan S and provided a
As Brexit becomes even more unclear, we cancer immunologists have been looking outward with a view to building stronger links with centres of excellence worldwide. I had the privilege of taking a representative delegation of cancer immunologists from across the faculty to
Enterprise activity continues to be an important facet of the University’s and Faculty’s strategic goals. Last year we were awarded two grants by the MRC to support our enterprise activity, Both schemes are available to the whole Faculty.
The Faculty were delighted to be awarded two MRC grants which will further the Enterprise agenda. Both are awarded with the aim of translating our high quality basic research to the clinic and are designed to fund translation rather than